bioAffinity Technologies Inc. $(BIAF)$ has announced that it received a notification from the Nasdaq Stock Market LLC regarding its non-compliance with Nasdaq Listing Rule 5550(b)(1). The company's stockholders' equity of $1,439,404 as of March 31, 2025, falls short of the required $2,500,000 for continued listing on the Nasdaq Capital Market. Despite this, bioAffinity Technologies' common stock will continue trading under the symbol "BIAF" while the company remains compliant with other listing requirements. A compliance plan is expected, and if not accepted, the company can request a hearing to delay any suspension or delisting actions. This notice is separate from a previous deficiency related to maintaining a minimum closing bid price of $1.00 per share.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.